Health

Source link : https://newshealth.biz/health-news/trial-breathes-new-life-into-neurotrophins-as-target-in-osteoarthritis/ Osteoarthritis (OA) pain is currently treated with analgesics of only limited efficacy and that come with significant adverse effects when used for long periods. Pain pathways mediated by neurotrophin molecules have emerged as potential drug targets in OA. This phase II trial, testing a fusion protein that binds a neurotrophin receptor to downregulate this pathway, […] […] More

Source link : https://newshealth.biz/health-news/gps-told-to-route-more-referrals-through-advice-system/ GPs in England expected to use specialist advice before referral under NHS target to divert a quarter of cases. Press Association Source link : https://www.medscape.com/s/viewarticle/gps-told-route-more-referrals-through-advice-system-2026a10009mt?src=rss Author : Publish date : 2026-03-30 20:29:00 Copyright for syndicated content belongs to the linked Source. The post GPs Told to Route More Referrals Through Advice System first appeared on News […] More

Source link : https://newshealth.biz/health-news/drop-the-beta-blocker-long-after-a-stabilized-mi-not-a-bad-idea-after-all/ NEW ORLEANS — The beta-blockers routinely used after myocardial infarction (MI) can be reasonably stopped after a year in some patients, the SMART-DECISION trial found. In stabilized heart attack survivors without heart failure or left ventricular (LV) systolic dysfunction, stopping the beta-blockers led to major clinical outcomes on par with a continuation strategy in terms […] […] More

Source link : https://newshealth.biz/health-news/glp-1-drugs-pick-up-another-win-this-time-in-psoriatic-arthritis/ DENVER — Adding a GLP-1 agonist to psoriasis medication significantly improved outcomes in patients with psoriatic arthritis (PsA) and overweight or obesity, a phase III randomized trial showed. After 36 weeks, almost a third of patients randomized to ixekizumab (Taltz) and tirzepatide (Zepbound) had at least 50% improvement in psoriatic arthritis status (ACR50) and 10% […] […] More

Source link : https://newshealth.biz/health-news/one-drug-wins-and-another-fails-for-long-covid-fatigue/ Fluvoxamine and metformin have anti-inflammatory and immunomodulatory properties that have led researchers to test their ability to prevent and treat long COVID and its symptoms. In a randomized trial, fluvoxamine led to a significant reduction in fatigue as measured by the Fatigue Severity Scale compared with placebo at day 60, with a 99% posterior probability […] […] More

Source link : https://newshealth.biz/health-news/8m-medicaid-enrollees-risk-coverage-loss-under-work-mandate-study-finds/ The full implementation of a federal Medicaid work requirement program will put about 8 million enrollees at risk of losing their Medicaid coverage. Most of those at risk of losing coverage have disabilities that would make it difficult to comply with the requirement, but don’t meet the official exemption criteria. The study is consistent with […] […] More

Source link : https://newshealth.biz/health-news/how-can-we-reach-the-patients-we-dont-see-regularly/ Let me tell you about two “new” patients I saw recently. One was a new patient who came to see me at the request of their newly found significant other, someone in their late 50s, who reported to me that the last time they’d seen a doctor was their discharge from the military just about […] […] More

Source link : https://newshealth.biz/health-news/new-and-emerging-developments-in-atopic-dermatitis-at-aad-2026/ As the 2026 American Academy of Dermatology (AAD) annual meeting continues in Denver, MedPage Today is offering another preview of its upcoming roundtable on new and emerging developments in atopic dermatitis. In this episode, moderator Peter Lio, MD, a clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine in Chicago, […] […] More

Source link : https://newshealth.biz/health-news/corn-tortillas-in-california-now-must-contain-folic-acid-more-states-may-follow/ Fifteen years after she lost her first baby to a rare and devastating birth defect, Andrea Lopez takes comfort in knowing that other Latina mothers might finally avoid the same pain. In January, California became the first state to require food makers to add folic acid, a crucial vitamin, to corn masa flour used to […] […] More

Source link : https://newshealth.biz/health-news/deferred-pci-safe-for-tavi-patients-with-coronary-disease/ NEW ORLEANS — For coronary artery disease patients undergoing transcatheter aortic valve implantation (TAVI), waiting to see if percutaneous coronary intervention (PCI) was also needed led to similar outcomes as doing both TAVI and PCI upfront, the randomized PRO-TAVI trial showed. Among nearly 500 patients, 24% of those who underwent PCI only if clinically indicated […] […] More

Source link : https://newshealth.biz/health-news/imaging-based-ffr-on-par-with-wire-for-pci-outcomes/ NEW ORLEANS — Revascularization treatment guided by fractional flow reserve calculated from an angiogram yielded similar outcomes as that guided by direct pressure wire measurement in randomized trials of two different software programs. In the ALL-RISE trial, the primary endpoint of 1-year all-cause mortality, myocardial infarction (MI), or unplanned clinically indicated revascularization occurred in 6.9% […] […] More

Source link : https://newshealth.biz/health-news/low-breast-cancer-recurrence-rate-with-radiotherapy-tailored-to-nodal-response/ Ten years after tailored radiotherapy (RT) for breast cancer, fewer than 3% of patients had locoregional recurrences (LRR), most during the first 5 years, a Dutch registry study showed. The overall LRR of 2.9% did not differ significantly across subgroups of patients with low-, intermediate-, or high-risk disease or between the risk groups. Both the […] […] More